EU awards $7.8M for kidney transplant biomarker development

04/29/2013 | GenomeWeb Daily News (free registration)

The European Commission is providing 13 research groups in Europe with $7.8 million to create biomarker-based tools for evaluating the health of patients who have undergone kidney transplants. The consortium, also known as BIOMARGIN, will develop noninvasive ways to detect allograft lesions and improve the survival of the kidney and patient over the long term.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA